Astrocytes play a central role in the central nervous system (CNS), maintaining brain homeostasis, providing metabolic support to neurons, regulating connectivity of neural circuits, and controlling blood flow as an integral part of the blood-brain barrier. They have been increasingly implicated in the mechanisms of neurodegenerative diseases, prompting a greater need for methods that enable their study. The advent of human induced pluripotent stem cell (iPSC) technology has made it possible to generate patient-specific astrocytes and CNS cells using protocols developed by our team and others as valuable disease models. Yet isolating astrocytes from primary specimens or from in vitro mixed cultures for downstream analyses has remained challenging. To address this need, we performed a screen for surface markers that allow FACS sorting of astrocytes. Here we demonstrate that CD49f is an effective marker for sorting functional human astrocytes. We sorted CD49f + cells from a protocol we previously developed that generates a complex culture of oligodendrocytes, neurons and astrocytes from iPSCs. CD49f + -purified cells express all canonical astrocyte markers and perform characteristic functions, such as neuronal support and glutamate uptake.
INTRODUCTION
Astrocytes are the most abundant cells in the human brain, playing an essential role in central nervous system (CNS) development and homeostasis (reviewed in 1 ). They provide trophic support for neurons 2 , promote formation and function of synapses 3, 4 , prune synapses by phagocytosis 5, 6 , and fulfill a range of other homeostatic functions, including water, ion and neurotransmitter buffering 7 . They also undergo a pronounced transformation called 'reactive astrogliosis' following injury and in disease 1, 8 . A wealth of studies have implicated astrocytes in the onset and progression of many neurodevelopmental and neurodegenerative diseases 9, 10 , prompting further research to identify potential novel astrocyte targets for therapeutic intervention. Investigations of astrocyte function have relied on reductionist cell culture models, of which many have been produced since the 1970s. The first method to purify primary astrocytes from rodent brains was based on selective adhesion to tissue culture plates, which eliminate most oligodendrocytes and microglia 11 , but still retain a large fraction of neurons. Furthermore, astrocytes selected with this method are primarily immature, proliferating cells, rather than post-mitotic astrocytes; they require serum to grow in vitro, which induces a reactive or disease pathological state 12 . While these methods have been extremely powerful for understanding many important astrocyte functions, due to their baseline pathological state they have had limited success in investigations of disease states of astrocytes.
More recently, alternative immunopanning methods have been developed by the Barres laboratory that take advantage of the cell-surface antigens Integrin Beta-5 (encoded by ITGB5) to purify rodent astrocytes 12 and GlialCAM (or HepaCAM) adhesion protein (in rodent cells, HepaCAM is also highly expressed by oligodendrocyte progenitor cells) 13 . Alternative commercial magnetic-activated cell sorting (MACS) systems have also been widely adopted. These methods allow researchers to isolate post-mitotic astrocytes, and in the case of immunopanned astrocytes, to maintain these cells in serum-free conditions from both rodent and human tissues. While these methods have provided incredibly pure and well-maintained astrocyte cultures, they have been largely focused on rodent cells. Studies based on primary human CNS cells have unfortunately been largely limited by the scarce availability of brain specimens. Our knowledge of astrocyte biology has thus mainly been built on rodent models, either in vivo or in vitro.
The advent of human embryonic stem cell and induced pluripotent stem cell (iPSC) technology has enabled large-scale generation of human astrocytes and other CNS cells that retain the genetic information of the patient, as powerful human in vitro models of disease (reviewed in 14 ) . Several protocols to generate astrocytes have been developed by independent groups, using either a specific gradient of patterning agents to mimic embryonic development [15] [16] [17] [18] [19] [20] [21] or overexpression of critical transcription factors 22, 23 . Usually, iPSC differentiation into astrocytes in monolayer cultures does not require a purification step; in recent years, however, more complex 3D cultures of CNS organoids have been established that contain neural progenitor cells, neurons, oligodendrocyte lineage cells and microglia, in addition to astrocytes 22, [24] [25] [26] [27] [28] [29] [30] [31] . As these culture systems are increasingly utilized to model CNS diseases, methods for purifying specific cell types are becoming highly desirable for transcriptomic and network analyses as well as functional assays. To our knowledge, the GlialCAM marker used for purifying adult primary astrocytes via immunopanning is not expressed in iPSC-derived astrocytes, unless they have been differentiated for over 100 days in culture 26 , making the identification of a novel surface marker that allows isolation of astrocytes from developing organoids a high priority.
Here we leveraged a differentiation protocol that we previously developed to generate oligodendrocytes 32 from mixed cultures that include neurons and astrocytes. Our unbiased screen for surface molecules on these cultures identified CD49f as a novel marker for purifying human iPSC-astrocytes from neurons and oligodendrocyte lineage cells through fluorescent-activated cell sorting (FACS). CD49f, encoded by the gene ITGA6, is a member of the integrin alpha chain family of proteins and interacts with extracellular matrices, including laminin. The Brain RNA-Seq database (https://www.brainrnaseq.org/) developed by the Barres lab confirmed that the ITGA6 expression is higher in human fetal and mature astrocytes compared to neurons, oligodendrocytes and microglia, although its expression is also high in endothelial cells. We show that CD49f can be used to FACS-purify astrocytes from a mixed culture containing oligodendrocyte lineage cells (encompassing oligodendrocyte progenitor cells, immature and mature oligodendrocytes) and neurons. CD49f + astrocytes express all typical astrocytic markers, display similar gene expression profiles to human primary astrocytes and iPSC-astrocytes derived from different protocols, and perform expected astrocyte functions in vitro (i.e., they support neuronal growth and synaptogenesis, generate spontaneous Ca 2+ transients, respond to ATP, and perform glutamate uptake). Taken together, our findings establish a novel astrocyte surface marker that can be used to purify iPSC-derived astrocytes and interrogate their role in models of neurodegenerative diseases.
RESULTS AND DISCUSSION A screen for astrocyte-specific surface markers reveals CD49f
We previously optimized a protocol to generate human oligodendrocytes from iPSCs [32] [33] , using chemically defined media and patterning through retinoic acid and sonic hedgehog signaling, to mimic the formation of OLIG2 + neural progenitors as it occurs embryonically in the developing spinal cord 34 . When OLIG2 + cell-enriched neural spheres are plated, neurons, astrocytes and oligodendrocyte progenitor cells migrate out in order between day 30 and day 65 32 . From day 65 on, immature oligodendrocytes can be purified by sorting for the O4 sulfated glycolipid antigen; we sought to develop an analogous sorting strategy to isolate astrocytes for further characterization and functional studies ( Fig. 1A) . To identify astrocyte-specific markers we tested 242 mAbs to cell surface antigens using the BD lyoplate (see methods), then we re-plated and fixed the sorted cells and stained for glial fibrillary acidic protein (GFAP), a well-known astrocyte-specific cytoplasm intermediate filament 35 . From this screen, we identified CD49f as a candidate for astrocyte purification. We then repeated the differentiation protocol using three independent iPSC lines from healthy subjects, where the fractions of FACS-isolated CD49f + cells were 41.69%, 41.20%, and 49.15% respectively ( Fig.  1B) . Using SOX9 as a nuclear marker for astrocyte quantification, we found an enrichment from an average of 61% in unsorted cells to >99% SOX9 + cells in the CD49f + FACS-purified fraction (Fig. 1C ,D). CD49f + cells were AQP4 + and/or GFAP + cells with morphologies typical to astrocytes, while the CD49ffraction was enriched with MAP2 + neurons and O4 + oligodendrocytes ( Fig. 1E ).
CD49f + cells express canonical astrocyte markers
CD49f + cells were highly heterogeneous in morphology, likely reflecting the complexity and diversity reported in vivo 36 ( Fig. 2A ). Interestingly, some CD49f-sorted cells were GFAP -AQP4 + (Fig. 2B ), in line with the reported heterogeneity of GFAP protein levels in different brain regions 37 . They also stained positive for established astrocyte makers GLAST (EAAT1), NFIa, VIM, and S100β, in addition to GFAP, AQP4, and SOX9 38 (Fig.  2C ). We performed RNA sequencing transcriptomic analysis on purified cells and found high expression of well-established astrocyte-specific, but not neuron or oligodendrocyte-specific genes, with low variability between lines ( Fig. 2D ). Hierarchical clustering of RNA-Seq data showed strong similarities between CD49f + astrocytes and hiPSC-astrocytes generated from an alternative differentiation protocol 21 as well as primary human astrocytes, versus clear differences from other cell types such as neurons, oligodendrocytes, microglia, and endothelial cells ( Figure 2D ). Despite the patterning during the first few days of differentiation with caudalizing and ventralizing agents retinoic acid and sonic hedgehog, it is interesting to note that the transcriptomic profile of our samples is very similar to the one of forebrain astrocytes generated by the Brennand lab 21 , raising the questions of whether astrocyte heterogeneity stems from regional differences 39 , and whether these differences can be recapitulated in a dish using iPSC-derived cells. It is not surprising that iPSC-astrocytes cluster closer to fetal than adult primary cells, as this is true for all iPSC-derived CNS cells 40 -again highlighting the importance of an astrocyte-specific cell surface marker that can be used to isolate astrocytes from organoids at this age. Nonetheless, as demonstrated below, iPSC-derived astrocytes acquire key characteristic functions of in vivo astrocytes, allowing in vitro functionality tests in patient-derived lines. This can be harnessed to investigate the role of astrocytes in the pathogenesis of both developmental and neurodegenerative disorders [41] [42] [43] .
Functional in vitro properties of CD49f + astrocytes CD49f + astrocytes release pro-inflammatory cytokines upon stimulation
A key function of astrocytes in the brain is responding to inflammatory stimuli (reviewed in 44, 45 ). To test this in our hiPSC-derived cells, we stimulated CD49f + astrocytes either with IL-1β and TNFα 46 or with IL-1α, TNFα, and C1q (the latter to test activation to the reactive neurotoxic A1 state that has been reported both in rodents and in human neurodegenerative diseases [42] [43] [44] [45] [46] [47] ). We assessed cytokine release after 24 hours by measuring the concentrations of different cytokines in the supernatant of stimulated and unstimulated cells. Pro-inflammatory cytokine secretion was significantly higher following both types of stimulation, with the greatest increase in IL-6 and soluble ICAM-1 secretion (Fig. 3A ). There were no major differences between stimulation with the two combinations of cytokines typically released by microglia, and this is likely explained by the dominance effect of TNFa, present in both cocktails. Notably, astrocytes stimulated with IL-1α, TNFα, and C1q expressed C3, an A1-specific astrocyte marker 42 , unlike untreated physiological astrocytes (Fig. 3B ). These A1-stimulated astrocytes also exhibited morphological changes when compared to unstimulated astrocytes -losing finer processes and becoming hypertrophied ( Fig. 3B ). These morphological changes have previously been observed in reactive astrocytes in vivo in a number of studies in response to different types of injuries (reviewed in 1, 48 ).
CD49f + astrocytes provide trophic support in co-cultures with neurons
To assess the capacity of our purified astrocytes to support neuronal function, we set up a co-culture by plating purified CD49f + astrocytes with hiPSC-derived neurons. Neurons that were co-cultured with astrocytes for two weeks displayed more developed electrophysiological properties than neurons cultured alone, including increased number of action potentials per 1s depolarizing stimulus, increased maximum firing frequency, increased maximum height of action potential, increased amplitude adaptation ratio, and decreased half-width of first action potential ( Fig. 4A ). Furthermore, neurons co-cultured with astrocytes exhibited spontaneous excitatory postsynaptic currents (sEPSC) indicating advanced synaptogenesis, while neurons cultured alone did not, as reported previously for adult human 13 and rodent 49 astrocytes (Fig. 4B ). We also fixed the cells and quantified the average area of MAP2 signal per neuron and found that neurons cocultured with CD49f + astrocytes had a larger MAP2 area than those cultured without astrocytes ( Fig. 4C ), suggesting an increase in neurite length in these cells. Together, these data show that CD49f + hiPSC astrocytes have the functional capacity to support neurite outgrowth, morphological maturation, neuronal function, and synapse formation.
Calcium signaling in CD49f + astrocytes
Next, we investigated whether purified astrocytes would exhibit calcium transients, as it is known that astrocytes have both spontaneous and inducible calcium signals that can be detected in vivo in different brain regions 50, 51 and in vitro 49 . We used Rhod-3/AM to monitor cytosolic calcium levels and found that, like primary purified human astrocytes in vitro and mouse astrocytes visualized in vivo, CD49f + astrocytes from all tested lines demonstrate spontaneous calcium transients ( Fig. 5A ). Furthermore, we assessed the ability of our CD49f + astrocytes to respond to extracellular ATP. We found that astrocytes from all three lines robustly responded to 60s application of extracellular ATP at 100 µM by generating calcium transients ( Fig. 5B ).
Neurotransmitter uptake by CD49f + astrocytes
Astrocytes are able to take up excessive glutamate, which is crucial for preventing neuronal glutamate excitotoxicity in the mammalian central nervous system 52 . To assess whether our hiPSC-astrocytes could modulate neurotransmitter concentrations in their surroundings, we incubated our sorted CD49f + astrocytes with glutamate in the media for three hours, then collected the supernatant and measured the remaining glutamate concentration using a colorimetric assay 23 . Our CD49f + astrocytes appeared to take up glutamate ( Figure 5C ), as primary astrocytes have been shown to do 53 .
CONCLUSION
Here we show that CD49f, a heterodimeric integrin membrane protein, is highly enriched in human iPSC-derived astrocytes. CD49f can be used to purify functional astrocytes out of co-cultures or organoids for downstream sequencing, immunohistochemistry, and functional interrogation of astrocytes in both physiological and pathological states. These findings facilitate the study of astrocyte function and dysfunction in CNS biology and neurodegeneration, especially using patient-derived iPSC models. 54 . iPSC lines were cultured and expanded onto Matrigel-coated dishes in mTeSR1 medium (StemCell Technologies) or StemFlex medium (ThermoFisher). Lines were passaged every 3-4 days using enzymatic detachment with Stempro Accutase (ThermoFisher; A1110501) for 5 minutes and re-plated in mTeSR1 medium with 10µM Rock Inhibitor (Y2732, Stemgent) for 24 hours. The five lines were used for CD49f + astrocyte isolation and Sox9 quantification, and lines 1, 2, and 3 were then used for subsequent functional studies.
METHODS

Induced pluripotent stem cell lines
Differentiation of hiPSCs into astrocytes
Cells were cultured in a 37°C incubator, at 5% CO2. hiPSCs were induced to the neural lineage and differentiated using our previously published protocol 32 . hiPSCs were plated at 1 × 10 5 cells per well on a matrigel-coated six-well plate in hPSC maintenance media with 10 µM Y27632 (Stemgent; 04-0012) for 24 hours. Cells were then fed daily with hPSC maintenance media. Once colonies were ~100-250 µm in diameter (day 0), differentiation was induced by adding neural induction medium (Table 1) . Cells were fed daily until day 8. On day 8, medium was switched to N2 medium (Tables 2,3) and cells were fed daily until day 12. On day 12, cells were mechanically dissociated using the StemPro™ EZPassage™ Disposable Stem Cell Passaging Tool (ThermoFisher; 23181010). Cells from each well were split into two wells of an ultra-low attachment 6well plate and plated in N2B27 medium (Table 4 ). From day 12 onwards, two-third media changes were performed every other day. On day 20, cells were switched to PDGF medium using a two-third media change (Table 5 ). On the same day, round aggregates with a diameter between 300 and 800µm and a brown center were picked. Picked spheres were plated (20 spheres per well of a 6-well plate) onto Nunclon-Δ plates coated with 0.1 mg mL −1 poly-L-ornithine (Sigma) followed by 10 µg mL −1 laminin (PO/Lam coating, ThermoFisher; 23017015). Spheres were allowed to attach for 24 hours and were gently fed with PDGF medium every other day. At day 60-80, spheres and the cells migrating out of the spheres were dissociated with StemPro Accutase (add catalog number) for 30 minutes and passed through a 70um strainer. The resultant single cell suspension was sorted for CD49f-positive cells. After the sort, cells were frozen in Synth-a-Freeze (ThermoFisher; A1254201) or plated onto PO/Lam coated 96well plates. 24 hours after plating, medium was switched to glial medium (Table 6 ) and cells were fed with two-third media changes every other day. Spheres remaining on the strainer at the time of the sort can be plated back onto a PO/Lam Nunclon-Δ plates for up to three times to maximize astrocyte yield. Fluorescence-activated cell sorting for CD49f + astrocyte isolation Cells were lifted by incubation with Stempro Accutase for 30 minutes. Cell suspension was triturated 8-10 times and passed through a 70µm cell strainer (Sigma; CLS431751) then diluted >7x with DMEM/F12 medium. Cells were spun in a 15mL conical tube at 300g for 5 minutes at room temperature. Supernatant was aspirated and the cell pellet was resuspended in 200uL of FACS buffer (PBS, 0.5% BSA, 2mM EDTA, 20mM Glucose) with 1:50 PE Rat Anti-Human CD49f antibody (BD Biosciences; 555736) and incubated on ice for 20 minutes. Cells were then washed in FACS buffer, pelleted at 300g for 5 minutes and resuspended in FACS buffer containing propidium iodide for dead cell exclusion. The respective unstained, CD49f-only stained, and propidium iodide-only stained controls were run in parallel. CD49f+ cells were isolated via FACS on an ARIA-IIu™ Cell Sorter (BD Biosciences) using the 100µm ceramic nozzle, and 20 psi. Data were analyzed using FCS Express 6 Plus (De Novo Software).
Freezing and thawing of CD49f + cells
CD49f + cells were frozen after isolation in cryogenic vials (Thermo Scientific) in Synth-a-Freeze (ThermoFisher; A1254201). Cells were then transferred into a Mr.Frosty (Thermo Scientific) container and placed overnight at -80°C. The next day, cryogenic vials were transferred to liquid nitrogen for long-term storage. To thaw the cells, the cryogenic vial was transferred in a 37°C water bath for 1-2 min, until partially thawed. Under a laminar flow hood, DMEM/F12 medium was added to 7X the original volume of the vial. Cell were then centrifuged at 300g for 5 minutes, resuspended in the appropriate amount of PDGF medium and plated onto plates coated with 0.1 mg/ml poly-L-ornithine (Sigma) followed by 10 µg/ml laminin (ThermoFisher; 23017015). The next day, cells were switched to glial medium and fed every other day.
Immunofluorescence
Cells were fixed in 4% paraformaldehyde for 10 minutes, washed 3X in PBS, and incubated for one hour in blocking solution (PBS containing 0.1% Triton-X100 and 5% donkey serum). Primary antibodies (see Antibody Table) were applied overnight at 4°C. The next day, cells were washed 3X in PBS, incubated with secondary antibodies (Alexa Fluor) and HOECHST for 1 hour at room temperature, washed 3X for 10 min in PBS. Secondary antibodies were used at 1:500 dilution (all Alexa Fluor from ThermoFisher). 
Intracellular Ca 2+ imaging
Cells were cultured on glass coverslips coated with 0.1 mg ml−1 poly-L-ornithine followed by 10 µg/ml laminin. For Ca 2+ dye loading, cells were treated with Rhod-3/AM (ThermoFisher; R10145) for 30 minutes at 37 °C, washed twice with glial medium and imaged 30-60 minutes later. Live fluorescence imaging of spontaneous Ca 2+ activity was done with an ArrayScan XTi high-content imager (ThermoFisher) equipped with a live cell module maintaining 37 °C, 5% CO2 and >90% relative humidity environment. Whole field of view images at 20x magnification were acquired with Photometrics X1 cooled CCD camera (ThermoFisher) at 4Hz for 2 minutes. For Ca 2+ imaging experiments involving drug application, cells were grown on 1.5x PO/Lam coated plastic coverslips (Nunc Thermanox) and then transferred to a heated (31°C) recording chamber mounted onto an upright Olympus BX61 microscope. Fluorescence was recorded at 2Hz by a cooled CCD camera (Hamamatsu Orca R 2 ). Images were taken 2 minutes before and 3 minutes after the addition of ATP (100 μM), and drug application was done via whole chamber perfusion for a period of 60s. For quantification of the change in intensity over time, astrocytes were outlined as regions of interest (ROIs) and analyzed with ImageJ software. [Ca 2+ ]i transients are expressed in the form of ΔF(t)/F0, where F0 is a baseline fluorescence of a given region of interest and ΔF is the difference between current level of fluorescence F(t) and F0. Fluctuations of ΔF(t)/F0 of less than 0.05 were considered non-responses.
Cytokine detection and measurement
Astrocytes were plated on PO/Lam coated 96 well plates and treated with 3 ng/mL IL-1α (Sigma; 3901), 30 ng/mL tumor necrosis factor alpha (R&D Systems; 210-TA-020) and 400 ng/mL C1q (MyBioSource; MBS143105) for 24h or with 10 ng/mL tumor necrosis factor alpha and 10ng/ml IL1-ß(R&D Systems; 401-ML-005) for 24h. The medium was collected and spun down at 1,500 rpm for 5 minutes to remove debris, and frozen at -80°C. Samples were thawed on ice and a ProcartaPlex Custom Panel of cytokines (ThermoFisher) was quantified using the Luminex instrument, as per the manufacturer's instructions.
Neuronal differentiation and co-culture with astrocytes
For neuronal differentiation, hiPSCs were plated in a 12-well plate in hPSC maintenance media with 10uM ROCK inhibitor (Y2732, Stemgent). The next day, the cells were induced and fed daily with neural induction media (DMEM/F12 (ThermoFisher; 11320033) 1:1 Neurobasal (ThermoFisher; 21103049 ) with 1x Glutamax, 1x N2 supplement, 1x B27 supplement without Vitamin A) with SB (20µM), LDN (100nM), XAV939 (1µM). On day 8, the media was switched to neural induction media with XAV939 (1µM), and the daily media changes continued. On day 15, cells were dissociated using accutase and either frozen in Synth-a-freeze, or plated in neuronal media (Brainphys (StemCell Technologies; 05790) with 1x GlutaMAX™-I, 1x B27 supplement (ThermoFisher; 17504001), and 10µM ROCK inhibitor) at 50k/well in a PO/Lam coated 96-well plate (Corning; 353376). On day 16, the media was switched to neuronal media with BDNF (40ng/mL), GDNF (40ng/mL), Laminin (1µg/mL), dbcAMP (250uM), ascorbic acid (200µM), PD0325901 (10µM), SU5402 (10µM), DAPT (10µM). Cells were fed every other day. PD0325901, SU5402, and DAPT were taken out of the media after two weeks. Astrocytes were plated on top of neurons on day 33 and cells were fed every other day with neuronal media.
Electrophysiology
For whole-cell recordings, neurons were visualized using an upright Olympus BX61 microscope equipped with a 40x objective and differential interference contrast optics. Neurons were constantly perfused with BrainPhys® medium (STEMCELL Technologies, Catalog #05790) preheated to 30-31°C. Patch electrodes were filled with internal solutions containing 130 mM K-gluconate, 6 mM KCl, 4 mM NaCl, 10mM Na-HEPES, 0. RNA sequencing and analysis RNA isolation was performed using the RNeasy Plus Micro Kit (Qiagen; 74034). Media was aspirated off CD49f + cells in culture, and cells were lysed in Buffer RLT Plus with 1:100 β-mercaptoethanol. Samples were then stored at -80°C until processed further according to manufacturer instructions. RNA was eluted in 17µl RNase free ddH2O and quantified with a Qubit 4 Fluorometer (ThermoFisher; Q33227). Paired-end RNAseq data were generated with the Illumina HiSeq 4000 platform following the Illumina protocol. The raw sequencing reads were aligned to human hg19 genome using star aligner 55 (version 2.4.0g1). Following read alignment, featureCounts 56 (v1.6.3) was used to quantify the gene expression at the gene level based on Ensembl gene model GRCh37.70. For re-analysis of human primary astrocyte RNAseq data from Zhang et al. 13 , we downloaded the raw RNAseq data from gene expression omnibus (GEO: accession GSE73721). Similarly, for comparison with a recently published human iPSCderived astrocyte dataset from TCW et al. 21 , we downloaded their RNAseq read data from GEO (accession GSE97904). The RNAseq data from the two published studies were processed using the same star/featureCounts pipeline as described above and then the gene level read counts were combined with the gene count data of our samples. Genes with at least 1 count per million (CPM) in more than 2 samples in the merged data were considered expressed and hence retained for further analysis, otherwise removed. Then the read count data were normalized using trimmed mean of M-values normalization (TMM) method 57 to adjust for sequencing library size difference and then corrected for batch using linear regression. To examine similarities among samples, hierarchical cluster analysis was performed based on the respective transcriptome-wide gene expression data. A, Schematic of hiPSC-astrocyte (iPSC-AS) protocol depicting matrix choice, growth factor composition, and major steps of the protocol leading to the CD49f sort. SB, SB431542; LDN, LDN193189; SAG, smoothened agonist; T3, triiodothytonine; RA, alltrans retinoic acid; PDGF, platelet-derived growth factor; HGF, hepatocyte growth factor; IGF-I, insulin-like growth factor-1; NT3, neurotrophin 3; AA, ascorbic acid; PO/lam, poly-ornithine and laminin coating.
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B, Representative flow cytometry plots of the CD49f sort of hiPSC-cells generated from 3 independent hiPSC lines using our protocol in A. Each cell line is represented by a different color. Plots for side scatter and forward scatter, duplet exclusions and live gates are depicted above the CD49-PE gate. Dot plot on the right shows the percentage of CD49f + cells obtained from independent differentiations across the 3 hiPSC lines, each of which is represented by a different color. A, Representative recordings of firing patterns of hiPSC-neurons at day 47 when cultured alone, or with astrocytes during days 33-47. Dot plots show the maximum number of evoked spikes per 1 second stimulus, the maximum firing frequency in hertz (Hz), the amplitude adaptation ratio between first and last action potential, and the maximum action potential height in mV. Different dot colors correspond to 3 different iPSC-AS lines. Error bars show mean ± standard deviation. p-values were calculated using a two-way, unpaired t-test.
B, Representative recordings of spontaneous excitatory post-synaptic currents measured in hiPSC-neurons at day 47 when cultured alone, or with astrocytes during days 33-47. Dot plot shows the average number of spontaneous excitatory postsynaptic currents per 30 seconds. Different dot colors correspond to 3 different iPSC-AS lines. Error bars show mean ± standard deviation. p-values were calculated using a twoway, unpaired t-test.
C, Representative immunofluorescence images showing MAP2 + neurons (cyan), GFAP + astrocytes (red), and DAPI nuclei in hiPSC-derived neurons at 40 days in vitro cultured alone or with astrocytes for one week. Scale bar, 50μm. Dot plot shows the average size of MAP2 + cells. Different dot colors correspond to 3 different iPSC-AS lines. Error bars show mean ± standard deviation. p-values were calculated using a two-way, unpaired t-test. 
